Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA, Europe, CHMP, Wegovy, Novo Nordisk, Bimervax, TG Therapeutics, Eli Lilly, Bristol Myers Squibb, Novartis, AstraZeneca
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, heart failure
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D, Roche, JNJ, Merck, Pfizer, Novartis, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, AbbVie
Eli Lilly to increase investment to $1B into new Irish manufacturing facility — report
Endpoints
Mon, 03/27/23 - 09:55 pm
Tags:
Eli Lilly, Ireland, drug manufacturing
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Tags:
Novo Nordisk, Rybelsus, diabetes, clinical trials, Eli Lilly
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
Motley Fool
Thu, 03/23/23 - 11:35 am
Tags:
Eli Lilly, Mounjaro
Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
PM Live
Wed, 03/22/23 - 10:15 am
Tags:
Roche, Eli Lilly, Alzheimer's disease, diagnostics
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Tags:
Flare Therapeutics, funding, Pfizer, Eli Lilly, Novartis, transcription factors
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
Tags:
AACR, Moderna Therapeutics, Allogene, AstraZeneca, Merck, Roche, Novartis, Eli Lilly, Innovent, Springworks, Biogene, Relay Therapeutics, Vivace Therapeutics
Eli Lilly signs CSO Daniel Skovronsky to $5M non-compete clause
Medical Marketing and Media
Mon, 03/20/23 - 09:47 am
Tags:
Eli Lilly, executives, Daniel Skovronsky, CSO
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Tags:
Sanofi, Lantus, insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance
Endpoints
Thu, 03/16/23 - 07:00 pm
Tags:
Eli Lilly, SEC, abortion, diversity, DEI, Indiana
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
Wed, 03/15/23 - 10:06 am
Tags:
insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Forbes
Tue, 03/14/23 - 11:27 am
Tags:
Novo Nordisk, drug pricing, insulin, diabetes, Eli Lilly
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III
BioSpace
Thu, 03/9/23 - 11:46 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab, clinical trials
Eli Lilly kicks off consumer campaign for diabetes drug Mounjaro
Medical Marketing and Media
Thu, 03/9/23 - 11:26 am
Tags:
Eli Lilly, Mounjaro, diabetes, DTC ads
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Tue, 03/7/23 - 11:45 am
Tags:
Volastra Therapeutics, Eli Lilly, funding, sovilnesib, Amgen, cancer
FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands
Fierce Pharma
Mon, 03/6/23 - 11:50 am
Tags:
Eli Lilly, Verzenio, breast cancer
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices
Fierce Pharma
Sun, 03/5/23 - 03:26 pm
Tags:
Eli Lilly, Novo Nordisk, Sanofi, insulin, Bernie Sanders, drug pricing
Eli Lilly licenses non opioid pain med for $40M upfront
Seeking Alpha
Thu, 03/2/23 - 09:58 am
Tags:
Eli Lilly, Confo Therapeutics, non-opioid pain treatments, CFTX-1554

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.